Roberta Sartori

6PUBLICATIONS
43CO-AUTHORS
Nutrigenomics and personalised nutritionCancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 29, 2026
Chemotherapy induces tissue NAD+ loss, and downregulation of NAD+ biosynthetic enzyme Nrk2 marks muscle wasting.

|Apr 03, 2023
NAD+ repletion with niacin counteracts cancer cachexia.

Marc Beltrà, Noora Pöllänen, Claudia Fornelli

|Feb 24, 2022
Iron supplementation is sufficient to rescue skeletal muscle mass and function in cancer cachexia.

Elisabeth Wyart, Myriam Y Hsu, Roberta Sartori

|Oct 23, 2021
The ERG1A K+ Channel Is More Abundant in Rectus abdominis Muscle from Cancer Patients Than that from Healthy Humans.

Sandra Zampieri, Marco Sandri, Joseph L Cheatwood

|Aug 05, 2021
Perturbed BMP signaling and denervation promote muscle wasting in cancer cachexia.

Roberta Sartori, Adam Hagg, Sandra Zampieri

|Jul 24, 2021
The Prognostic Value of Low Muscle Mass in Pancreatic Cancer Patients: A Systematic Review and Meta-Analysis.

Elisa Sefora Pierobon, Lucia Moletta, Sandra Zampieri

Pageof 1

Frequent Collaborators

3 joint publications

Elisa Sefora Pierobon

3 joint publications

Sandra Zampieri

3 joint publications

Fabio Penna

2 joint publications

Lucia Moletta